Tradestie Institutional Equity Comparison Engine
IMMP vs BHST โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IMMP Overall Edge
IMMP Captures Institutional Edge (3โ0 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Immutep Limited American Depositary Shares (IMMP) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, IMMP trades at 7.1x Forward P/E with -409.3% operating margin (+633.5% YoY revenue) versus BHST at N/M Forward P/E and -18.0% operating margin (+3.8% YoY). In options structure, IMMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
IMMP
IMMP 7.1x vs BHST N/M Fwd P/E
Growth & Margin Winner
IMMP
Op Margin -409.3% vs -18.0% ยท YoY +633.5% vs +3.8%
Momentum & Technical Winner
IMMP
1Y +73.7% vs -79.4% ยท 52W Pos 56% vs 6%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
IMMP
NASDAQ
Immutep Limited American Depositary Shares
Pharmaceutical Preparations
$3.11
-9.06% 1D
Market Cap
$25.2M
1M Return
-1.89%
1Y Return
+73.74%
Forward P/E
7.1x
Unified AI Score
58.4 / 100
HOLD
Tech 62.0
Fund 38.0
Flow 50.0
Mom 40.0
BHST
NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap
$29.9M
1M Return
-22.62%
1Y Return
-79.4%
Forward P/E
N/M
Unified AI Score
58.2 / 100
HOLD
Tech 75.0
Fund 57.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
IMMP +73.74%
BHST -79.4%
Spread: +161.27 pp (IMMP Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
IMMP TTM Op. Margin: -409.3%
BHST TTM Op. Margin: -18.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IMMP vs BHST. Trailing 12-month operating profitability (IMMP -409.3% vs BHST -18.0%) and valuation multiples (IMMP 7.1x vs BHST N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | IMMP | BHST | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $25.2M | $29.9M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | 7.1x | N/M | Lower Multiple | IMMP |
| Forward P/E Ratio Valuation | 7.1x | N/M | Lower Multiple | IMMP |
| Revenue Growth (YoY) Growth | +633.5% | +3.8% | Higher Growth | IMMP |
| Operating Margin (TTM) Profitability | -409.3% | -18.0% | Higher Margin | BHST |
| Net Profit Margin Profitability | 0.0% | -31.2% | Higher Margin | IMMP |
| Return on Equity (ROE) Capital Efficiency | -77.3% | -142.5% | Higher ROE | IMMP |
| 52-Week Range Position Momentum | 56% ($0โ$5) | 6% ($1โ$7) | Stronger Trend | IMMP |
| Beta / 30D Volatility Risk Regime | -7.10ฮฒ ยท 118% Vol | 0.25ฮฒ ยท 86% Vol | Lower Realized Risk | BHST |
| Unified Institutional Score Composite Signal | 58.4 / 100 (HOLD) | 58.2 / 100 (HOLD) | Higher Composite | Tie |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full IMMP vs BHST Buy Guide
IMMP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
BHST
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither IMMP nor BHST registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.